Great West Life Assurance CO Arvinas, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Arvinas, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 14,524 shares of ARVN stock, worth $263,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,524

Previous 14,524 -0.0%

Holding current value

$263,465

Previous $386,000 6.99%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$24.46 - $40.4 $78,320 - $129,360	-3,202 Reduced 18.06%	14,524 $386,000
Q1 2024 May 13, 2024	SELL	$36.38 - $52.31 $97,898 - $140,766	-2,691 Reduced 13.18%	17,726 $732,000
Q4 2023 Feb 13, 2024	BUY	$14.19 - $42.33 $56,774 - $169,362	4,001 Added 24.37%	20,417 $835,000
Q3 2023 Nov 14, 2023	BUY	$19.64 - $28.21 $54,677 - $78,536	2,784 Added 20.42%	16,416 $322,000
Q2 2023 Aug 10, 2023	BUY	$21.73 - $31.43 $31,508 - $45,573	1,450 Added 11.9%	13,632 $340,000
Q1 2023 May 12, 2023	SELL	$26.15 - $37.26 $631,313 - $899,530	-24,142 Reduced 66.46%	12,182 $333,000
Q4 2022 Feb 10, 2023	BUY	$32.47 - $57.24 $130,821 - $230,619	4,029 Added 12.48%	36,324 $1.25 Million
Q3 2022 Nov 01, 2022	BUY	$41.87 - $57.99 $1.35 Million - $1.87 Million	32,295 New	32,295 $1.44 Million
Q2 2022 Aug 09, 2022	BUY	$36.01 - $74.24 $656,462 - $1.35 Million	18,230 Added 102.5%	36,016 $1.51 Million
Q1 2022 May 12, 2022	BUY	$60.27 - $81.57 $944,913 - $1.28 Million	15,678 Added 743.74%	17,786 $1.27 Million
Q2 2021 Aug 11, 2021	BUY	$60.45 - $84.26 $967 - $1,348	16 Added 0.76%	2,108 $162,000
Q1 2021 May 17, 2021	BUY	$58.19 - $91.37 $48,646 - $76,385	836 Added 66.56%	2,092 $137,000
Q3 2020 Nov 17, 2020	SELL	$22.99 - $36.34 $591,670 - $935,246	-25,736 Reduced 95.35%	1,256 $29,000
Q3 2020 Nov 13, 2020	BUY	$22.99 - $36.34 $591,670 - $935,246	25,736 Added 2049.04%	26,992 $637,000
Q2 2020 Aug 17, 2020	BUY	$29.88 - $56.74 $21,244 - $40,342	711 Added 130.46%	1,256 $42,000
Q4 2019 Feb 11, 2020	BUY	$15.39 - $44.38 $8,387 - $24,187	545 New	545 $22,000
Q3 2019 Oct 25, 2019	SELL	$21.55 - $27.61 $22,153 - $28,383	-1,028 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$15.96 - $23.8 $16,406 - $24,466	1,028 New	1,028 $0

Others Institutions Holding ARVN

# of Institutions

231

Shares Held

68.5M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $965M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Arvinas, Inc. Transaction History